Abnormal Uterine Bleeding (AUB)
AUB is bleeding from the uterus outside pregnancy that is abnormal in regularity, frequency, duration, or volume of flow (it does not refer to bleeding associated with pregnancy). It's one of the most common reasons for gynecologic visits in reproductive-aged women.
Normal menstrual parameters (for reference)
| Parameter | Normal |
|---|
| Regularity | Regular |
| Frequency | Every 24-38 days |
| Duration of flow | Normal (~4.5-8 days) |
| Volume | Normal (not heavy, not light) |
Any deviation from these (irregular cycles, too frequent/infrequent, prolonged flow, heavy volume, intermenstrual bleeding) qualifies as AUB.
FIGO PALM-COEIN Classification
Since 2011, FIGO classifies AUB etiology into structural (PALM) and nonstructural (COEIN) causes:
Structural causes (PALM) - visible/detectable on imaging or histology
- P - Polyp: endometrial or endocervical polyps
- A - Adenomyosis: endometrial glands/stroma within the myometrium; increasingly diagnosed pre-hysterectomy via ultrasound/MRI criteria
- L - Leiomyoma: uterine fibroids - the most common genital tract tumor (occurs in up to half of women over 35). Submucosal fibroids are most likely to cause bleeding; number/size doesn't strongly predict bleeding
- M - Malignancy and hyperplasia: unopposed estrogen exposure drives a spectrum from cystic/adenomatous hyperplasia to atypia to invasive carcinoma. Abnormal bleeding is the most frequent symptom of invasive cervical cancer - any visible cervical lesion needs biopsy rather than waiting on cytology results
Nonstructural causes (COEIN)
- C - Coagulopathy: systemic bleeding disorders (e.g. von Willebrand disease)
- O - Ovulatory dysfunction: chronic anovulation (e.g. PCOS) causes unopposed estrogen and irregular endometrial buildup, leading to long cycles with heavy, prolonged, unpredictable bleeding
- E - Endometrial: primary disorders of endometrial hemostasis/local mechanisms causing heavy bleeding despite regular ovulatory cycles
- I - Iatrogenic: hormonal contraception (breakthrough bleeding), IUDs, anticoagulants
- N - Not yet classified: rare/poorly defined causes (e.g. arteriovenous malformations, cesarean scar defects)
Clinical approach
- Exclude pregnancy first - AUB terminology does not apply to gestational bleeding
- Structured history (bleeding pattern, associated symptoms) plus pelvic exam
- Pelvic ultrasound is the initial imaging of choice; MRI or hysteroscopy for further characterization of structural lesions
- Consider AUB-M workup (endometrial biopsy) in higher-risk patients: age over 45, obesity, diabetes, hypertension, PCOS, nulliparity, late menopause, unopposed estrogen exposure, tamoxifen use, or Lynch syndrome/family history of breast, colon, or endometrial cancer
- Check CBC (anemia is common, especially with submucosal leiomyoma or proliferative endometrial causes) and coagulation studies if indicated
- Direct management at the identified etiology
Recent evidence check: A quick literature check for meta-analyses/systematic reviews on PALM-COEIN in the last 2 years didn't surface results contradicting this framework - it remains the current standard (FIGO system, most recently reaffirmed through 2011 publication with ongoing refinement).
Sources: Berek & Novak's Gynecology (structural/nonstructural classification, leiomyoma and malignancy sections); supplemented with FIGO PALM-COEIN literature (Munro et al., Int J Gynaecol Obstet 2011) and
StatPearls overview.